January, 2019
First Patient Enrolled in Pivotal Huntingtin-Lowering Trial
Posted on January 31, 2019
This week, Ionis Pharmaceuticals issued a press release stating that the Phase 3 trial of the huntingtin-lowering therapy formerly known…
Read MoreTwo Announcements From Drug Companies
Posted on January 24, 2019
This week, we learned that the SIGNAL trial has completed recruitment for its Phase 2 study of VX15/2503 (pepinemab), a…
Read More2018 Research Year In Review Webinar Available
Posted on January 17, 2019
If you weren’t able to join us for the 2018 HD Research Year-in-Review webinar or would like to have another…
Read MoreAmerican Society of Human Genetics Chooses Huntington’s Disease as Topic for 2019 Essay Contest
Posted on January 10, 2019
The American Society of Human Genetics (ASHG) is a nonprofit organization whose mission is to advance human genetics in science,…
Read More2018 Research Year in Review Webinar
Posted on January 3, 2019
To complement our 2018 Research Report, George and Leora will be sharing this year’s HD research highlights in our 2018…
Read More